Celgene
Top Ten most popular articles on Pharmafile.com this week!
November 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Celgene, GSK, Novo Nordisk, politics, popular, top 10, vaccines
The biggest news this week came from Israeli biotech Zion Medical after it was announced that HIV drug Gammora was …
Former Celgene CEO Bob Hugin loses in US midterm elections
November 7, 2018Research and Development Bob Hugin, Celgene, Trump, midterms, republican, us politics
Former Celgene CEO Bob Hugin has failed in his bid to win over the people of New Jersey, after voters …
Celgene’s Otezla impresses at Phase 3 in scalp psoriasis
October 9, 2018Manufacturing and Production, Research and Development Celgene, pharma, psoriasis
Celgene has unveiled new Phase 3 data for Otezla (apremilast), its inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine …
Celgene’s Otezla produces “meaningful benefits” beyond traditional metrics in plaque psoriasis
September 13, 2018Research and Development Celgene, otezla, pharma, psoriasis
Celgene made its voice heard amongst the chorus of new psoriasis data emerging from the European Academy of Dermatology and …
Agios appoints Celgene’s Jacqualyn Fouse as new CEO
September 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, COO, Celgene, Jacqualyn Fouse, agios
The Massachusetts-based oncology specialist Agios Pharmaceuticals has appointed former Celgene President and COO Jacqualyn Fouse as their new Chief Executive …
Celgene’s Revlimid combo meets Phase 3 goal in relapsed/refractory indolent lymphoma
July 24, 2018Manufacturing and Production, Research and Development Celgene, Revlimid, lymphoma, pharma
Celgene has lifted the curtain on new Phase 3 data for its combo of Revlimid (lenalidomide) plus rituximab (R2) in …
Celgene and Acceleron’s blood disorder drug smashes endpoints at Phase 3
July 11, 2018Research and Development Acceleron, Celgene, beta-thalassemia, luspatercept, pharma
Celgene and Acceleron have lifted the curtain on new Phase 3 data for their erythroid maturation agent (EMA) luspatercept, confirming …
Celgene showcases strong Otezla data in psoriatic arthritis
June 13, 2018Research and Development Celgene, EULAR, otezla, pharma
Celgene has seized the opportunity at the Annual European Congress of Rheumatology in Amsterdam to reveal positive new data for …
Celgene bring in new CFO to steady the ship
June 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene
The fact that Celgene is currently sailing through choppy waters is no secret to anyone within the industry, it’s facing …
Celgene bring in new CFO to steady the ship
June 4, 2018Medical Communications, Sales and Marketing Celgene, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical
The fact that Celgene is currently sailing through choppy waters is no secret to anyone within the industry, it’s facing …
Juno CEO and Co-founder steps down in wake of Celgene acquisition
April 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Juno, appointment, pharma
Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …
Juno CEO and Co-founder steps down in wake of Celgene acquisition
April 25, 2018Medical Communications, Research and Development Celgene, appointment, juno therapeutics, pharma
Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …
Celgene’s COO heads to the exit
April 3, 2018Manufacturing and Production, Medical Communications, Sales and Marketing Celgene, Mark Alles, Scott Smith, biotech, drugs, pharma, pharmaceutical
Celgene has had a rough six months, its share price since the beginning of October has dropped from $146 to …
bluebird backs own CAR-T prospect, takes option to co-develop with Celgene
March 29, 2018Sales and Marketing Bluebird Bio, CAR T, CAR-T, Celgene, biotech, drugs, pharma, pharmaceutical
Biotech companies showing faith in their own prospect drug candidates is not an unusual occurrence, some do it to extremes. …
Top Ten most popular articles on Pharmafile.com this week
March 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma
As me move startlingly quickly towards Easter, it’s time for another Top Ten rundown. This week, Celgene surprised the industry …
Latest content
FibroFind appoints Lee Borthwick as CEO
